KRAS and pancreatic neoplasm: Interestingly, the K-Ras wild-type BxPC-3 cells also showed a ~32% decrease in clonal growth (Fig. 2e), suggesting that the impact of USP10 depletion in pancreatic cancer cells is independent of the K-Ras status.